Format

Send to

Choose Destination
See comment in PubMed Commons below
Nat Rev Urol. 2012 Jan 10;9(2):111-8. doi: 10.1038/nrurol.2011.225.

XMRV and prostate cancer--a 'final' perspective.

Author information

1
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA. ksfanos@jhmi.edu

Abstract

XMRV was first described in 2006, when it was identified in samples isolated from prostate cancer tissues. However, studies have since shown that XMRV arose in the laboratory and was formed by genetic recombination between two viral genomes carried in the germline DNA of mice used during serial transplantation of the CWR22 prostate cancer xenograft. These new findings strongly imply that XMRV does not circulate in humans, but is only present in the laboratory. Thus, there is no reason to believe that it has any role in the etiology of prostate cancer or other diseases.

Comment in

PMID:
22231291
PMCID:
PMC4029112
DOI:
10.1038/nrurol.2011.225
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Support Center